FLUCELVAX TETRA s aigu 2024/2025 10 x 0.5 ml
7680674820062
CH-67482
J07BB02
08.08.
1 / 3
google
Details
- Product number
- 6748202
- CPT
- -
- Packaging group
- 10
- Unit
- Fertigspritze(n)
- Composition
- haemagglutininum influenzae A (H1N1) (Virus Stamm A/Wisconsin/67/2022 (H1N1)-like: derived from A/Georgia/12/2022 CVR-167) 15 µg, haemagglutininum influenzae A (H3N2) (Virus Stamm A/Massachusetts/18/2022 (H3N2)-like: derived from A/Sydney/1304/2022) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Austria/1359417/2021-like: reassortant from B/Singapore/WUH4618/2021 (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Phuket/3073/2013-like: reassortant from B/Singapore/INFTT-16-0610/2016 (Yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, magnesii chloridum hexahydricum, natrii dihydrogenophosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.7 mg, kalium 0.1 mg, residui: polysorbatum 80, cetrimidum, propiolactonum.
Articles (1)
Flucelvax Tetra, Injektionssuspension
Injektionssuspension
10
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
haemagglutininum influenzae A (H1N1)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum influenzae A (H3N2)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum influenzae B
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum influenzae B
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
natrii chloridum
|
- | Substance | HNIDK |
|
kalii chloridum
|
- | Substance | HNIDK |
|
magnesii chloridum hexahydricum
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas dihydricus
|
- | Substance | HNIDK |
|
kalii dihydrogenophosphas
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
1.7 MG | Substance | HBESI |
|
kalium
|
0.1 MG | Substance | HBESI |
|
polysorbatum 80
|
- | Substance | RESI |
|
cetrimidum
|
- | Substance | RESI |
|
propiolactonum
|
- | Substance | RESI |
Authorization holder
Vifor (International) Inc.
9014 St. Gallen
Authorization information
- Swissmedic authorization number
- 67482
- Drug name
- Flucelvax Tetra, Injektionssuspension
- Galenic form
- INJFS
- ATC Code
- J07BB02
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 04/05/2021
- Authorization expiration date
- 08/04/2026
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FLUCELVAX TETRA s aigu 2024/2025 10 x 0.5 ml
- Description (DE)
- FLUCELVAX TETRA o Nadel 2024/2025 10 x 0.5 ml
- Market launch
- 19/07/2024
- Market withdrawal
- 30/06/2025
- Narcotic (BTM)
- No